$ARIA Company News Ariad falls after wild ride upward,

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2014 at 3:05 PM

$ARIA Company News

Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy

Why Heron (HRTX) Has A Bright Short-Term Future? - Tale of the Tape 8:37 a.m. Today - Zacks.com
Tug Of War In Ariad Pharmaceuticals 1:36 p.m. Jan. 28, 2014 - benzinga.com
Ariad Pharmaceuticals (ARIA) Showing Signs Of A Dead Cat Bounce Today 9:47 a.m. Jan. 28, 2014 - TheStreet.com
Benzinga's M&A Chatter for Monday January 27, 2014 4:21 p.m. Jan. 27, 2014 - benzinga.com
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk 11:34 a.m. Jan. 27, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Highlighted As Today's Perilous Reversal Stock 10:38 a.m. Jan. 27, 2014 - TheStreet.com
Top Trending Tickers On StockTwits For January 27 8:20 a.m. Jan. 27, 2014 - benzinga.com
Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press! 3:40 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Shares Continue to Surge Amidst Buyout Rumors 3:06 p.m. Jan. 24, 2014 - benzinga.com
Ariad Pharnaceuticals Continues To Rally 2:32 p.m. Jan. 24, 2014 - benzinga.com
Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft Provides on of the Few Havens of Strength 2:32 p.m. Jan. 24, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Hit a Three-Month High Today 1:58 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Surges: Stock Moves 12.1% Higher - Tale of the Tape 9:18 a.m. Jan. 24, 2014 - Zacks.com
Top Trending Tickers On StockTwits For January 23 10:15 a.m. Jan. 23, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Is Up Today 10:13 a.m. Jan. 23, 2014 - TheStreet.com
Ariad Joins Rumor Mill: Hope May Trump Reality 9:54 a.m. Jan. 23, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Jan. 23, 2014 - benzinga.com
ARIA Stock – Ariad Shares Pop on Potential Buyout Rumors 3:34 a.m. Jan. 23, 2014 - InvestorPlace.com
Benzinga's M&A Chatter for Wednesday January 22, 2014 5:31 p.m. Jan. 22, 2014 - benzinga.com
Ariad +4.3% AH, Daily Mail reports that pharmas are circling 5:19 p.m. Jan. 22, 2014 - Seeking Alpha

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tetragon's September Factsheet Offers Unique Insights

A Peek into Tetragon's Financial Playbook Every once in a while, you come across a player in the finance world that operates by its own rules. Tetragon Financial Group is one of those mavericks, and they've dropped their September 2026 Monthly Factsheet. Now here's a company that knows how to keep you guessing while serving up some real financial meat. Investment Strategy...

CACI Hits $50K Milestone in Service Dog Program

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

How Dental Cleaning Frequency Boosts Oral Health

Cleaning Up Confusion on Dental Visits Never thought I'd be waxing poetic about gum health, but here we are. You know what they say, ain't no business like show business—and today's show is all about the pearly whites context, courtesy of Dr. Calvin Despain over in Moses Lake, Washington. Apparently, keeping that grin free from plaque isn't as simple as a quick brush...

Birth Injury Lawsuit Secures $19.1M Award in Michigan

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

Duolingo Faces Legal Storm: Investors Called to Act

Stirring the Pot at Duolingo You know what's worse than learning a new language? Finding out the company teaching it might have pulled a few fast ones on the market. That's right, folks, buckle up because Duolingo (NASDAQ: DUOL) is in hot water with a class action lawsuit hanging over its head, like a cloud of bad grammar questions. What's Up with the Lawsuit? This isn't...

AstroRad Vest Makes Spaceflight History at Smithsonian

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Air Force Officer's Pretrial Solitary Challenged

High Stakes at Joint Base Anacostia-Bolling Let's get real, the courtroom showdown set for November 17 over at Joint Base Anacostia-Bolling isn’t just another blip on the radar. We're talking about Major Jason P. Watson, a seasoned Air Force officer with an unblemished track record and more tours than most folks care to count. Monument Legal is at his side, hammering at...

FirstService Unveils New LA Luxury Living Insights

Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....

Barco Brings HDR Cinema Home with Kinepolis Kortrijk

A New Chapter in Cinema Projection Ah, Belgium, the land of waffles and apparently, cutting-edge cinema tech. That's right, Barco is bringing their HDR by Barco system to its own backyard in Kortrijk, teaming up with Kinepolis to shake things up. It's not just any expansion—it's a homecoming of sorts. The company's laser cinema magic has already made face time in the...

Anthropic's IPO Preparations Stir Investor Curiosity

Anthropic's Entrance: A New Horizon in AI Investment Gritty times afoot in the tech trenches, and Anthropic's prepping for an IPO ain't just a blip on the radar—it's a sledgehammer moment for folks keeping their eye on AI. Leverage Shares, through their Themes branch, are sniffing out opportunities to create new investment products. They're tiptoeing around launching...